The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020
José R. Franco,Giuliano Cecchi,Massimo Paone,Abdoulaye Diarra,Lise Grout,Augustin Kadima Ebeja,Pere P. Simarro,Weining Zhao,Daniel Argaw +8 more
TL;DR: Togo and Côte d’Ivoire were the first countries to be validated for achieving elimination of HAT as a public health problem at the national level and applications from three additional countries are under review by the World Health Organization.
read more
Abstract: Background In the 20th century, epidemics of human African trypanosomiasis (HAT) ravaged communities in a number of African countries. The latest surge in disease transmission was recorded in the late 1990s, with more than 35,000 cases reported annually in 1997 and 1998. In 2013, after more than a decade of sustained control efforts and steady progress, the World Health Assembly resolved to target the elimination of HAT as a public health problem by 2020. We report here on recent progress towards this goal. Methodology/principal findings With 992 and 663 cases reported in 2019 and 2020 respectively, the first global target was amply achieved (i.e. fewer than 2,000 HAT cases/year). Areas at moderate or higher risk of HAT, where more than 1 case/10,000 people/year are reported, shrunk to 120,000 km2 for the five-year period 2016–2020. This reduction of 83% from the 2000–2004 baseline (i.e. 709,000 km2) is slightly below the target (i.e. 90% reduction). As a result, the second global target for HAT elimination as a public health problem cannot be considered fully achieved yet. The number of health facilities able to diagnose and treat HAT expanded (+9.6% compared to a 2019 survey), thus reinforcing the capacity for passive detection and improving epidemiological knowledge of the disease. Active surveillance for gambiense HAT was sustained. In particular, 2.8 million people were actively screened in 2019 and 1.6 million in 2020, the decrease in 2020 being mainly caused by COVID-19-related restrictions. Togo and Côte d’Ivoire were the first countries to be validated for achieving elimination of HAT as a public health problem at the national level; applications from three additional countries are under review by the World Health Organization (WHO). Conclusions/significance The steady progress towards the elimination of HAT is a testament to the power of multi-stakeholder commitment and coordination. At the end of 2020, the World Health Assembly endorsed a new road map for 2021–2030 that set new bold targets for neglected tropical diseases. While rhodesiense HAT remains among the diseases targeted for elimination as a public health problem, gambiense HAT is targeted for elimination of transmission. The goal for gambiense HAT is expected to be particularly arduous, as it might be hindered by cryptic reservoirs and a number of other challenges (e.g. further integration of HAT surveillance and control into national health systems, availability of skilled health care workers, development of more effective and adapted tools, and funding for and coordination of elimination efforts).
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
01 Apr 2023
TL;DR: In this article , the safety and efficacy of acoziborole in adult and adolescent patients with gambiense HAT were evaluated in a multicentre, prospective, open-label, single-arm, phase 2/3 study, where patients were observed in hospital until day 15 after treatment administration then for 18 months as outpatients with visits at 3, 6, 12 and 18 months.
52
The Pathogenesis of African Trypanosomiasis.
TL;DR: African trypanosomes are bloodstream protozoan parasites that infect mammals including humans, where they cause sleeping sickness, and variants are associated with chronic kidney disease, particularly in the context of virus-induced inflammation such as coronavirus disease 2019.
43
The Pampa del Indio project: District-wide quasi-elimination of Triatoma infestans after a 9-year intervention program in the Argentine Chaco
Ricardo E. Gürtler,María Sol Gaspe,Natalia Paula Macchiaverna,Gustavo Fabián Enriquez,Lucía I. Rodríguez-Planes,María del Pilar Fernández,Yael M. Provecho,Marta Victoria Cardinal +7 more
TL;DR: In this paper , the authors implemented an insecticide-based intervention program and assessed its long-term effects on house infestation and bug abundance in a resource-constrained municipality (Pampa del Indio, northeastern Argentina) inhabited by creole and the Qom indigenous people (2007-2016).
33
Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
TL;DR: The history of drug discovery for HAT is reviewed with special emphasis on the discovery, pre-clinical development, and operational challenges of the clinical trials of fexinidazole, which greatly facilitates the diagnosis and treatment algorithm for gHAT, increasing the attainable coverage and paving the way towards the envisaged goal of zero transmission by 2030.
29
Pathogenicity and virulence of African trypanosomes: From laboratory models to clinically relevant hosts
TL;DR: A review of the current understanding of trypanosome determinants of infection progression and severity, covering laboratory models of disease, as well as human and livestock disease, is provided in this paper .
20
References
Human African trypanosomiasis
TL;DR: Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas.
909
Human African trypanosomiasis
TL;DR: If national control programmes, international organisations, research institutes, and philanthropic partners engage in concerted action, elimination of this disease might even be possible, the World Health Organization has stated.
880
Epidemiology of human African trypanosomiasis
TL;DR: Sustainable elimination of the gambiense HAT, defined as the interruption of the transmission of the disease, was considered as a feasible target for 2030, since rhodesiense H AT is a zoonosis, where the animal reservoir plays a key role, and the interruptionOf the disease’s transmission is not deemed feasible.
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
TL;DR: Diagnostic staging to distinguish early-stage from late-stage disease when the CNS in invaded is crucial but remains problematic, and new drugs are in the pipeline for treatment of CNS human African trypanosomiasis, giving rise to cautious optimism.
433
The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward.
TL;DR: The World Health Organization (WHO) Expert Committee on HAT Control and Surveillance held in 1995, in consideration of the huge uncertainties between the reported cases and the factual field situation, estimated that the true number of cases was at least 10 times more than reported.
Related Papers (5)
Floyd J. Frost,Rebecca L. Calderon,Gunther F. Craun +2 more
- 15 Jul 2005